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Synucleinopathies are a group of progressive disorders character-
ized by the abnormal aggregation and accumulation of α-synuclein
(aSyn), an abundant neuronal protein that can adopt different con-
formations and biological properties. Recently, aSyn pathology was
shown to spread between neurons in a prion-like manner. Proteins
like aSyn that exhibit self-propagating capacity appear to be able to
adopt different stable conformational states, known as protein
strains, which can be modulated both by environmental and by
protein-intrinsic factors. Here, we analyzed these factors and found
that the unique combination of the neurodegeneration-relatedmetal
copper and the pathological H50Q aSyn mutation induces a signifi-
cant alteration in the aggregation properties of aSyn. We compared
the aggregation ofWT and H50Q aSynwith andwithout copper, and
assessed the effects of the resultant protein species when applied to
primary neuronal cultures. The presence of copper induces the for-
mation of structurally different and less-damaging aSyn aggregates.
Interestingly, these aggregates exhibit a stronger capacity to induce
aSyn inclusion formation in recipient cells, which demonstrates that
the structural features of aSyn species determine their effect in neu-
ronal cells and supports a lack of correlation between toxicity and
inclusion formation. In total, our study provides strong support in
favor of the hypothesis that protein aggregation is not a primary
cause of cytotoxicity.
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Synucleinopathies are a group of neurodegenerative disordersthat include Parkinson’s disease (PD), dementia with Lewy
bodies, and multiple system atrophy. Although the clinical mani-
festations in these disorders are heterogeneous, ranging from
movement impairment to dementia, they all share the abnormal
accumulation of α-synuclein (aSyn) in proteinaceous inclusions
(1). The vast majority of synucleinopathy cases are sporadic. Nev-
ertheless, mutations in the gene encoding for human aSyn have
been reported in both familial and sporadic forms of synucleino-
pathies. In addition to gene multiplications, six point-mutations
have been described to cause familial forms of PD: A30P, E46K,
H50Q, G51D, A53T, and A53E (2, 3).
aSyn is a soluble 140-residue intrinsically disordered protein that
is abundant in neuronal cells, in particular in presynaptic terminals
(4). The primary sequence of aSyn can be divided into three re-
gions: (i) the N-terminal domain, with strong propensity to adopt
α-helical structure, responsible for membrane binding; (ii) the
central region, known as nonamyloid component, displays high
aggregation propensity and is crucial for the amyloidogenicity of the
entire protein; and (iii) the C-terminal region, highly acidic and
disordered, described as a chaperone-like domain (5). Although the
biological function of aSyn is still not well understood, increasing
evidence suggests it plays a major role in the synapse, where it
regulates synaptic vesicle release upon functional multimerization
(6). Remarkably, all pathological point-mutations are located in the
N-terminal region, required for membrane interactions (3).
Misfolding and aggregation of aSyn is a central event in synu-
cleinopathies. In the case of PD and dementia with Lewy bodies,
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aSyn accumulates mainly in intraneuronal inclusions called Lewy
bodies (LBs) and Lewy neurites (LNs) (7). The major component
of these inclusions is aggregated and phosphorylated aSyn on serine
129 (S129) (8), which adopts fibrillar morphology compatible with
that of amyloids (7). LBs and LNs are abundant in various regions
of diseased brains, such as the midbrain, hippocampus, and cor-
tex, which exhibit neuronal cell loss and degeneration (9, 10). The
mechanisms triggering aSyn aggregation are not clear, nor is the
relationship of aSyn aggregation with pathology. Several theories
attempt to explain the toxicity of misfolded/aggregated aSyn, in-
cluding the impairment in the endoplasmic reticulum trafficking
pathway, dysfunction of mitochondria, blocking of protein clear-
ance mechanisms, alteration of axonal transport, and disruption of
the plasma membrane (11–13). The precise nature of the toxic aSyn
species is still unclear, although it is believed that specific oligo-
meric species might be cytotoxic, rather than the mature aggregates
(14, 15).
Based on the Braak staging hypothesis (16) and on the obser-
vation of LB pathology in young dopaminergic neurons grafted into
the brains of PD patients (17), it was proposed that aSyn pathology
might spread in a prion-like manner. Subsequently, in vitro and in
vivo studies confirmed the ability of aSyn to be released/secreted
and taken up by neighboring cells (18–20), further supporting the
prion-like spreading of aSyn.
Environmental factors, such as exposure to pesticides or metals,
are thought to increase the risk for PD and, possibly, other syn-
ucleinopathies (21, 22). Indeed, deregulation of metal homeostasis,
including copper, manganese, zinc, iron, and lead, is characteristic
of these disorders (23, 24). However, there is still no unequivocal
evidence for a causative role of metals in synucleinopathies. In
particular, the precise relationship between those metals and
aSyn in the brain is not clear, although they bind to and promote
the aggregation of the protein in vitro (25, 26).
In the present study, we systematically screened for the effect
of transition metals on the intracellular aggregation of disease-
associated aSyn mutants and found a significant effect of copper(II)
ions (Cu2+) on the H50Q mutant. We produced recombinant
aggregates from WT and H50Q aSyn variants in the presence
and absence of Cu2+, performed detailed biophysical and struc-
tural analyses, and assessed their impact on neuronal cells. Im-
portantly, our studies of the interplay between environmental and
genetic factors affecting aSyn aggregation support dissociation
between cytotoxicity and intracellular aggregation, forming the
basis for future studies aimed at targeting specific species of aSyn
as therapeutic strategies.
Fig. 1. Copper ions promote the intracellular accumulation of H50Q aSyn inclusions. (A) The addition of Cu2+ to the medium of cells transfected with
different aSyn mutations revealed the formation of intracellular inclusions only in the presence of the H50Q aSyn mutant (white arrows). (Scale bar, 5 μm.)
(B) The effect observed was not associated with an increase in intracellular levels of expression of the H50Q mutant, as determined by immunoblot analysis.
(C) The interaction between Cu2+ and H50Q promotes an increase in cytotoxicity compared with WT −Cu2+, WT +Cu2+, and H50Q −Cu2+. MW, molecular
weight/molecular mass. *P < 0.05; **P < 0.01.















Copper(II) Induces H50Q aSyn Aggregation in Human Cells. Transition
metals, such as copper, interact with aSyn and modify its ag-
gregation properties (26). To assess the interplay between Cu2+
and aSyn mutations, we took advantage of an established cell
model of aSyn aggregation in human H4 neuroglioma cells and
used it as a system to screen the effect on five disease-associated
aSyn mutants. We supplemented the cell culture medium with
CuCl2 24 h after transfection with plasmids encoding for the
different aSyn mutants and incubated cells for 24 h. Upon im-
munohistochemistry and microscopy analysis we observed that
Cu2+ promoted the formation of intracellular inclusions with the
H50Q aSyn (Fig. 1A). This effect was not because of a change in
the levels of expression of the H50Q mutant, which remained
identical to those of WT aSyn (Fig. 1B). Interestingly, we ob-
served an increase in cytotoxicity in cells expressing H50Q in the
presence of Cu2+ (Fig. 1C). Importantly, the effect of Cu2+ on
the H50Q aSyn mutant appears to be specific to this cation,
because other relevant transition metals (24) did not induce the
formation of aSyn inclusions (SI Appendix, Fig. S1). Therefore,
we decided to focus our studies on the characterization of the
interplay between H50Q aSyn and Cu2+.
The Effect of Cu2+on aSyn Aggregation in Vitro. First, we evaluated the
effect of Cu2+ on the aggregation of WT and H50Q aSyn (Fig. 2A).
The kinetics of amyloid fibril formation usually follows a sigmoidal
curve that reflects a nucleation-dependent growth mechanism (27).
Both in the absence and presence of Cu2+, WT aSyn aggregation
followed this kinetics. In the absence of Cu2+, the WT aSyn re-
action (WT –Cu2+) exhibited a long lag phase of ∼100 h followed
by a fast increase in thioflavin-t (Th-T) signal that reached maxi-
mum fluorescence intensity after ∼250 h of incubation in the
conditions tested. The presence of Cu2+ (WT +Cu2+) accelerated
the aggregation reaction, shortening the lag phase to ∼50 h and,
consistently, the equilibrium was reached at ∼200 h. We found a
distinct scenario with the H50Q mutant. Although the aggregation
of H50Q in the absence of Cu2+ (H50Q –Cu2+) also followed a
typical sigmoidal curve, the lag phase was shorter than for WT
aSyn (∼25 h), followed by an exponential phase that plateaued at
∼90 h. In contrast, in the presence of Cu2+ (H50Q +Cu2+), ag-
gregation was strikingly faster, lacking a detectable lag phase, and
Th-T signal remained very weak throughout the reaction, sug-
gesting either the formation of nonfibrillar amyloid species or re-
duced aggregation. For WT aSyn, the presence of Cu2+ led to an
increase in Th-T binding at the end of the reaction, whereas for the
H50Q mutant it resulted in the opposite effect (Fig. 2B). To fur-
ther confirm that the four samples aggregated and, especially, that
the weak Th-T signal in H50Q + Cu2+ did not correspond to a
marked reduction in the amount of deposited protein, we per-
formed a sedimentation assay, measuring the protein remaining in
the supernatant after centrifugation. In this assay, all samples
showed similar amounts of insoluble material (Fig. 2C), despite the
differential binding to Th-T. Finally, we assessed the potential de-
pendence of aSyn aggregation on Cu2+ concentration, from sub- to
suprastoichiometric concentrations, using the Th-T-binding assay.
With both aSyn variants, an increase in Cu2+ concentration caused a
shortening of the lag phase, although this effect was limited to the
equimolar ratio. Exposing aSyn to suprastoichiometric Cu2+ con-
centration did not significantly accelerate the aggregation kinetics of
WT or H50Q (SI Appendix, Fig. S2) relative to an equimolar ratio.
Another neurodegeneration-related metal, iron, was introduced in
the aggregation assay, but no effect was observed, indicating that the
effect of Cu2+ on aSyn aggregation is probably specific for this
cation (SI Appendix, Fig. S2).
Next, we performed biophysical characterization of the result-
ing aggregates using circular dichroism (CD), attenuated total
reflectance–Fourier transform infrared spectroscopy (ATR–FTIR),
1-anilinonaphthalene-8-sulfonic acid (ANS) binding, and trans-
mission electron microscopy (TEM). We analyzed the secondary
structure of the samples by CD before and after aggregation. As
expected, freshly prepared aSyn samples, in the presence or absence
of Cu2+, exhibited a characteristic negative CD peak at 200 nm,
consistent with the lack of significant secondary structure in aSyn,
because it is known to be an intrinsically disordered protein (SI
Appendix, Fig. S3A). After aggregation, the CD spectra strongly
changed, showing a minimum at around 216 nm, consistent with the
presence of β-sheet structure. Deconvolution of the ATR–FTIR
raw spectra of aggregated states into the corresponding contributing
components (r2 < 0.998 in all cases) indicated that both WT –Cu2+
and WT +Cu2+ shared similar secondary structure elements (SI
Appendix, Fig. S3B). The peak at 1,623–1,641 cm−1, assignable to
intermolecular β-sheet structure, dominated both spectra (Table 1).
However, the ratio between the β-sheet and the disordered spectral
component was higher in the absence than in the presence of Cu2+
(2.0 and 1.3). The intermolecular β-sheet component was also the
main contributor to the H50Q –Cu2+ spectra with a ratio between
this signal and that of the disordered state similar to that observed
with WT –Cu2+ (1.9). In contrast, in the case of H50Q +Cu2+, the
intermolecular β-sheet signal did not dominate the spectra but
contributed the same amount as the disordered regions (ratio of
1.0) with an additional increase in β-turn content by 27%. Thus, the
presence of Cu2+ resulted in fewer ordered aggregates for both the
WT and the H50Q mutant, but the decrease in β-structure was
more pronounced for H50Q aSyn. Structural differences of the
Fig. 2. Biophysical characterization of the effect of copper ions on the
aggregation of WT and H50Q aSyn. (A) Aggregation kinetics of WT and
H50Q aSyn with and without Cu2+ evaluated by normalized Th-T binding at
the indicated time points. Fluorescence intensity peak at 482 nm was used to
probe for amyloid formation. (B) Fluorescence intensity at the end-time
point of the Th-T binding assay. (C) Remaining amount of soluble aSyn de-
termined by sedimentation assay at the end time point of aggregation.
(D) TEM images of the resulting aggregates stained with uranium acetate.
(Scale bar, 500 nm.) (E) Partial PK digestion of the aggregates visualized by
Coomasie staining of SDS/PAGE gels. Each lane represents different di-
gestion times: 0, 1, 2.5, 5, and 10 min.
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aggregates were also determined using the ANS binding assay
(SI Appendix, Fig. S3C). With both aSyn variants, the presence of
Cu2+ increased the ANS fluorescence of the aggregates (more
than 1.5-fold and 3-fold increase in WT and H50Q, respectively),
suggesting that Cu2+ increased the exposure of hydrophobic sur-
faces in the resulting aggregates. The initial soluble species did not
show differences in ANS binding among them, suggesting that the
impact of Cu2+ on the exposure of hydrophobic clusters in aSyn
assemblies occurs during the aggregation process. The morphol-
ogy of the aggregated samples was further investigated by TEM
(Fig. 2D). Both WT –Cu2+ and WT +Cu2+ formed well-defined
and classic amyloid filaments. This scenario was different for the
H50Q mutant, where the presence of Cu2+ induced the forma-
tion of nonfibrillar amorphous aggregates. Overall, the secondary
structure found in the aggregates and their morphology correlated
well with their relative ability to bind Th-T and is indicative of a
different conformational effect of Cu2+ in WT and in H50Q aSyn.
In addition, we examined the resistance of each aSyn aggregate to
proteolysis by performing a time-dependent partial proteinase
K (PK) digestion. We found that the species assembled in pres-
ence of Cu2+ displayed decreased resistance to proteolysis, whereas
those formed without Cu2+ exhibited a strongly resistant core
(Fig. 2E). Notably, in all cases the most susceptible region was
the C terminus, as evidenced by the use of an antibody recog-
nizing this region of the protein (SI Appendix, Fig. S4).
Because spreading of disease pathology might depend on the
ability of the transmitted protein to seed aggregation in the re-
cipient cell, we investigated the capacity of the aggregates of WT
and H50Q aSyn, formed in the absence and presence of Cu2+, to
influence the aggregation of monomeric aSyn. To this end, the
time-dependent decrease in the concentration of monomeric aSyn
was monitored using NMR spectroscopy, which allows the highly
sensitive detection of the initial steps of aggregation. Species
formed without Cu2+ displayed a strong seeding activity, rapidly
decreasing the amount of free monomers in solution. However,
this activity was reduced when the aggregates formed in the
presence of Cu2+ were used as seeds. Indeed, H50Q +Cu2+ did
not induce significant monomer consumption, indicating the ab-
sence of seeding activity at the time points analyzed (Fig. 3).
aSyn–Cu2+ Complexes at the Histidine 50 Site. Because the histidine 50
(H50) residue is key for anchoring Cu2+ binding to aSyn, the results
suggested that the critical step for the effects observed in
Cu2+-mediated aSyn aggregation might be the formation aSyn–Cu2+
complexes at this site. In vitro NMR (28) and electron para-
magnetic resonance (26, 29) experiments have suggested that the
ion binds in a square planar or tetrahedral distorted geometry, in-
volving 2 or 3 N ligands and 2 or 1 O ligands, respectively (29–31).
Models A and B (SI Appendix, SI Molecular Simulations) have been
proposed in the literature (28, 29, 32). The Cu2+ ion binds to the
H50 side chain in both of them. The three additional ligands are the
H50 amide group, a water molecule, and either V48 carbonyl O
(model A) or V49 deprotonated amide (model B). Quantum me-
chanics/molecular mechanics simulations were carried out to test
their structural stability (SI Appendix, SI Molecular Simulations). All
of the coordination bonds exhibited relatively small fluctuations
around their average values, except for the Cu2+–V48 carbonyl
and Cu2+–V49 amide. This finding suggests an interconver-
sion between the two forms. Added to the models in which H50
participation in binding to aSyn would involve the formation of an
intramolecular macrochelate or would lead to intermolecular
metal-bridged protein molecules (33), our calculations suggested
that: (i) both models could be significantly populated binding
modes; (ii) aSyn conformation is preorganized to accommodate the
square planar conformation of Cu2+, suggesting the latter may bind
using a conformational selection mechanism (34); and (iii) Cu2+ is
able to bind independently to the imidazole nitrogen of H50 in a
N2O2 (A) or N3O1 (B) interconverting ligand donor sets, with the
additional ligands mentioned above. In contrast, the H50Q variant
lacks all these modes of Cu2+ binding, indicating differences with
the WT protein, possibly underlying different conformations. Other
models, initially considered, were discarded (SI Appendix, SI
Molecular Simulations).
aSyn Aggregates Are Cytotoxic When Applied to Primary Neuronal
Cultures. The aSyn aggregates we generated in the various condi-
tions had distinct conformational and seeding properties. Thus, we
next asked whether they might have differential effects when ap-
plied to cultured cells. We exposed rat primary cortical cultures
for 13 d to the species resulting from aSyn aggregation. We found
that all aSyn species were toxic on neuronal cultures as assessed by
the release of adenylate kinase to the medium because of cell
damage (Fig. 4A). Quantification of the remaining cells and of the
percentage of condensed nuclei also revealed cell loss after
treatment with aSyn aggregates (Fig. 4 B and C). Immunostaining
against microtubule-associated protein 2 (MAP2) confirmed that
the reduced number of cells was a result of neuronal loss. We also
found a reduction in the average neurite length, particularly pro-
nounced in the cultures treated with WT –Cu2+ and H50Q –Cu2+
(Fig. 4D). Consistently, these cultures displayed reduced levels of
MAP2, as determined by immunoblot analysis (Fig. 4E). Because
MAP2 is specifically present in dendrites, we also used Tau as an
axonal marker of mature neurons (35) to assess whether these
projections could also be affected, but found no significant dif-
ferences (Fig. 4E). To measure possible synaptic damage induced
by the aSyn aggregates, we quantified the levels of presynaptic
(synapsin and synaptophysin) and postsynaptic (postsynaptic
density protein 95) markers (SI Appendix, Fig. S5). We observed a
significant reduction of these markers in cells that were treated
with WT –Cu2+ and H50Q –Cu2+. Because the application of
Table 1. Secondary structure composition of the fibrils formed
by WT −Cu2+, WT +Cu2+, H50Q −Cu2+ and H50Q +Cu2+
Sample β-Sheet intermolecular Disordered Turns
WT −Cu2+ 56.73 27.63 15.63
WT +Cu2+ 46.10 36.33 17.56
H50Q −Cu2+ 54.61 29.06 16.32
H50Q +Cu2+ 38.97 39.17 21.84
The assignments are represented in percentage and were attributed to
each peak observed according to Susi and Byler (75).
Fig. 3. Copper ions reduce the seeding capacity of aSyn aggregates. Time-
dependence of 1H NMR spectra of monomeric aSyn upon addition of ag-
gregation seeds [4% (vol/vol)]. The integrated intensity of 1H signals in two
regions (0.50–1.05 ppm, 6.50–8.00 ppm) was calculated and plotted as a
function of time. The solution with 70-μM monomeric protein (WT or
H50Q) contained either no Cu2+ or an equimolar concentration of Cu2+, as
indicated.














Fig. 4. Cellular effects as a result of the exogenous application of aSyn aggregates. (A) Cytotoxicity quantification in cultures exposed to aggregates compared
with the vehicle control, measured as the presence of adenylate kinase in the medium. (B) Cell death quantification, measured as the reduction in the number of
cells. (C) Increase in the percentage of condensed nuclei in the same experiment represented in B. (D) Quantification of neurite length of cells exposed to aggregates
compared with the vehicle control (Left) and representative images of MAP2 stained cultures, used to obtain the former parameter (Right). (Scale bars, 20 μm.) (E)
Quantification of MAP2 and Tau levels by Western blot. (F) Astrogliosis caused by the application of aSyn aggregates, measured by Western blot quantification of
GFAP (Left), and representative images evidencing the presence of reactive astrocytes (Right). (Scale bars, 20 μm.) *P < 0.05; **P < 0.01; ***P < 0.001 for comparison
between samples and their appropriate vehicle control. #P < 0.05; #P < 0.01 for comparison between different samples.
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pathological aSyn species has been reported to induce a glial re-
sponse in vivo (20, 36), we investigated the state of the astrocytes by
probing for glial fibrillary acidic protein (GFAP). An increase in
GFAP levels could only be detected in cells exposed to WT –Cu2+
and H50Q –Cu2+, likely because of the development of reactive
astrocytes, as GFAP staining revealed a phenotype compatible with
reactive astrocytes (37) (Fig. 4F).
Overall, we demonstrated that aggregated recombinant aSyn
species promoted neuronal death and damage. Importantly, the
effects observed depended on the type of aggregate that was used,
being more acute in the case of aggregates formed without Cu2+.
aSyn Aggregates Induce the Formation of Phosphorylated aSyn
Inclusions. Next, we analyzed the capacity of the different aggre-
gated species of aSyn to induce the conversion of endogenous
aSyn into misfolded/aggregated forms in cultured cells. The ex-
perimental set-up was the same as described above. We per-
formed immunostaining with an antibody against phosphorylated
aSyn (p-aSyn) on S129, because aggregated aSyn is commonly
phosphorylated in this residue, as in LBs (8). This approach also
enabled us to specifically detect intracellular aSyn, and not ex-
ternal protein, as this was not phosphorylated and, therefore,
could not react with the antibody against p-aSyn (38). Although
we observed a wide distribution of p-aSyn in the cell body of ve-
hicle-treated cells (Fig. 5A), those exposed to aSyn aggregates
displayed more intense and concentrated signal, corresponding to
inclusions positive for p-aSyn (Fig. 5A). Cells treated with H50Q
–Cu2+, and particularly with WT –Cu2+ species, contained fewer
inclusions. In contrast, those treated with WT +Cu2+ and H50Q
+Cu2+ presented several p-aSyn+ inclusions, which we classified as
neuritic, perykarial, and nuclear (Fig. 5B). Because of technical
limitations in the quantification of inclusions in neurites, we per-
formed a semiquantitative assessment of the frequency of all types
of inclusions in Table 2. We also performed quantification of total
p-aSyn on S129 by immunoblot (Fig. 5C). Strikingly, the occur-
rence of intracellular inclusions was highly specific to the type of
aggregates applied to the cells. We observed neuritic inclusions in
all treatments, although very few were observed in cells treated
with WT –Cu2+ and H50Q –Cu2+. With the latter treatment
(H50Q –Cu2+), we also observed dispersed perykarial inclusions.
Cultures treated with aggregates formed in the presence of Cu2+
presented more inclusions in neurites and perykaria. Specifically,
cells treated with H50Q +Cu2+ displayed the largest number of all
types of inclusions (Table 2). To rule out issues of unspecificity of
the p-aSyn antibody (39), we validated the observed staining with
an antibody against total aSyn (SI Appendix, Fig. S6). The in-
soluble nature of the induced p-aSyn inclusions was confirmed
using an established fixation protocol during the immunostaining
that included the presence of Triton X-100 to remove soluble
proteins and structures (38). Furthermore, detection of cellular
aSyn in the insoluble fraction in the cultures displaying more in-
clusions (those treated with WT +Cu2+ and H50Q +Cu2+) cor-
roborated the presence of aggregated aSyn (Fig. 5D).
We next aimed at determining which particular aSyn protein
composed the inclusions observed. The use of an antibody spe-
cific for rat aSyn revealed that part of the inclusions present in
neurites and perykaria are mainly formed by human recombinant
protein that was internalized, whereas all nuclear inclusions were
made up of endogenous aSyn (Fig. 6A). To further investigate
the presence of exogenous aSyn in the nuclear inclusions, we
labeled the aggregates formed by H50Q +Cu2+ in vitro, as those
were the most active in promoting these types of inclusions, and
applied them to the cells using the same procedure as above.
Immunostaining against p-aSyn confirmed the absence of exoge-
nous aSyn in the nuclear inclusions (Fig. 6B). To unequivocally
validate this finding, labeled aSyn species were applied to neurons
expressing GFP and live cell imaging was performed. Recombinant
material was internalized into the cells, but was unable to cross the
nuclear membrane (Fig. 6C). Therefore, we confirmed that nuclear
p-aSyn inclusions were exclusively formed by endogenous aSyn.
We performed further characterization of the p-aSyn+ inclu-
sions. On the one hand, inclusions present in neurites were vis-
ible in Tau+ projections, confirming their axonal localization.
They appeared as puncta or short filaments and, part of them,
showed a discontinuous linearity that could be followed up to the
neuronal cell body (Fig. 5B and SI Appendix, Fig. S7A). On the
other hand, perykarial inclusions were examined by costaining
with Lamin B1, which stains the nuclear envelope. We confirmed
their presence in the cell body and around the cell nucleus
(SI Appendix, Fig. S7B). Both neuritic and perykarial inclusions
appeared positive for heat-shock protein 90 (Hsp90), a molec-
ular chaperone commonly present in LBs and other protein
Fig. 5. Formation of S129 p-aSyn+ inclusions upon exposure to aSyn aggre-
gates. (A) Representative images of each culture showing the presence of p-
aSyn (S129) inclusions in cells treated with exogenous aggregates. (Scale bars,
20 μm.) (B) Distinct types of p-aSyn inclusions classified as neuritic, perykarial and
nuclear. (Scale bars, 20 μm.) (C) Western blot measurements of p-aSyn (S129) in
cell lysates. (D) Soluble/insoluble distribution of the cellular aSyn detected with a
rat-specific aSyn antibody. **P < 0.01; ***P < 0.001 for comparison between
samples and their appropriate vehicle control. ##P < 0.01 for comparison be-
tween different samples.














aggregates (40) (SI Appendix, Fig. S7 A and B). Finally, the lo-
calization of nuclear inclusions was confirmed by costaining with
Hoechst, a widely used nuclear stain. On average, one to six
p-aSyn+ round structures appeared in the nuclei of cells con-
taining inclusions. These were usually present in areas that were
Hoechst− . The lack of costaining with nucleolar markers
(nucleolin and fibrillarin) ruled out their presence in the nucleoli
(SI Appendix, Fig. S7C). However, we could detect costaining
with ubiquitin, one of the main hallmarks of disease-associated
protein deposits (41). Despite the presence of p-aSyn inclusions,
we did not detect significant alteration in markers of the heat
shock response or of the endoplasmic reticulum stress in our
experimental conditions (SI Appendix, Fig. S8).
Discussion
PD is characterized by the accumulation of aSyn+ fibrillar inclu-
sions, and is associated with an imbalance in metal ion homeostasis
(e.g., Cu, Zn, and Fe) (24). In the present study we first screened
the effect of Cu2+ over different disease-associated aSyn mutants.
After the exogenous addition of this cation, H50Q aSyn was the
only mutant exhibiting intracellular accumulation. The interplay
between this variant and Cu2+ was highly specific, because upon
testing other relevant metals (24), no H50Q aSyn inclusions were
observed. This unique synergy is not surprising, considering that
the N-terminal region of aSyn in which H50 acts as a key metal
anchoring residue constitutes the preferential binding interface for
Cu2+ (28, 26, 33, 42). Previous studies, using other cell models,
revealed that exposure to Cu2+ promotes inclusion formation and
toxicity in aSyn-expressing cells (43) and that the H50Q aSyn
mutant exhibits a higher aggregation propensity when expressed
intracellularly (44). Consistently, in our screen we detected a spe-
cific increase in aSyn aggregation only with the combination of
H50Q aSyn and Cu2+, an effect that exacerbates cytotoxicity.
In cell-free conditions and in agreement with previous evidence
(26), we show here that Cu2+ specifically increases the aggregation
propensity of WT aSyn, reducing the lag phase and accelerating
self-assembly. However, the effect of Cu2+ in the aggregation of
H50Q aSyn is clearly different from that in the WT protein,
resulting in a very rapid formation of amorphous aggregates that—
despite containing intermolecular β-sheet structure—bind to Th-T
with low affinity, suggesting major structural differences that in-
clude, among other features, a larger increase in the exposure of
hydrophobic surfaces as revealed by ANS binding. These differ-
ences are probably because of the substitution of a key metal
binding site (H50) in the H50Q mutant, which mainly coordinates
Cu2+, in comparison with other metal cations that may have higher
affinities for other residues in the aSyn sequence (45). Despite the
reported variability, all aSyn species share a common aggregation
core with a less-compacted region mainly composed by the C ter-
minus of the polypeptide. This finding is in agreement with pre-
vious data reporting the poor participation of the C-terminal
domain in fibril formation, which indeed remains mainly disor-
dered instead of acquiring the typical β-sheet structure (46). The
definition of aSyn as a prion-like protein is intimately linked to an
intrinsic seeding activity of, at least, some misfolded conformations.
We observe that the distinctive structural features introduced by
the presence of copper ions are mirrored in differential seeding
activities. Among the species tested, the one formed by H50Q
+Cu2+ is the only one not acting as an efficient seed in our con-
ditions. The aggregates formed by H50Q +Cu2+ differ significantly
Table 2. Table presenting semiquantification of the frequency
of p-aSyn (S129) inclusions in each culture measured from
immunostaining pictures
aSyn species Neuritic Perykarial Nuclear
WT −Cu2+ + — —
WT +Cu2+ ++ +++ +
H50Q −Cu2+ + + —
H50Q +Cu2+ +++ ++ +++
Fig. 6. Distribution of exogenous and endogenous aSyn in the S129 p-aSyn
inclusions. (A) Neuritic (Top), perykarial (Middle), and nuclear (Bottom)
p-aSyn inclusions show partial or total colocalization with rat-specific aSyn.
(B) Presence and absence of labeled aSyn aggregates in perykarial and nu-
clear p-aSyn inclusions. (C) Confocal live cell imaging of cultures exposed to
labeled aSyn aggregates and infected with a GFP-expressing lentivirus
demonstrating the cellular distribution of the exogenous species at different
time points after exposure. (Scale bars, 10 μm.)
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from the other ones, being mainly amorphous, with low Th-T
binding and lacking seeding activity. Taken together, these findings
show that the combination of the H50Q mutation and Cu2+ pro-
motes the formation of atypical aSyn aggregates, probably repre-
senting off-pathway species.
As mentioned above, H50 is crucial in the binding of Cu2+ to
aSyn. Our quantum mechanics/molecular mechanics simulations
suggest that the protein backbone and a water molecule complete
the coordination of Cu2+. The participation of H50 in metal binding
may induce different folding of the protein through the formation of
this macrochelate or may act as an intermolecular metal-anchoring
point bridging different protein molecules, explaining how H50–
Cu2+ complexation might impact on aSyn aggregation (33). Added
to that, the independent, noninteractive H50–Cu2+ binding mode
described in our study and those reported for Cu+ binding to aSyn
(47) indicate that the H50 site constitutes a unique target for in vivo
Cu2+/Cu+ redox chemistry and oxidative damage, a reaction that
might lead to a cascade of structural alterations promoting oligo-
merization and the subsequent amyloid aggregation of aSyn (33).
Thus, H50 might play an important role in the structures adopted by
soluble aSyn at the beginning of the aggregation reaction and, likely,
of the polymerization rates and the final conformation in the
resulting aggregates, which would explain the conformational di-
versity of WT +Cu2+ and H50Q +Cu2+ aggregates.
A relevant approach to assess aSyn propagation consists of the
induction of aSyn aggregation, upon treatment with preformed
fibrils or aggregates, in cultured cells without previous aSyn pa-
thology (48–50). Here we used a similar approach with the ob-
jective to further characterize the aSyn species being studied,
considering their distinct biophysical features. We used primary
neuronal cultures as others have done in the past (51). We found
that, although all types of recombinant aSyn aggregates promote
cell death, the strongest effect occurs with those assembled in the
absence of Cu2+. The specific decrease in neurite length suggests
deterioration of neuronal processes precedes cell death. The ab-
sence of significant alteration in Tau levels indicates that dendritic
arborization is more susceptible to aSyn toxicity than axons. At the
end point of our experiments, the axonal network is mature and
complex (35), probably exhibiting increased resistance to external
insults. The damage induced by aSyn aggregates is also evident in
synaptic terminals. However, the toxicity linked to exogenous aSyn
is still not fully established, probably because it depends on the
cellular type, on the endogenous levels of aSyn, or on the type and
properties of the aSyn species used (38, 49, 52–54). In the present
study, two of four types of mature aSyn aggregates tested were
significantly more toxic, strongly affecting neuronal structures.
Interestingly, along with the neuronal damage observed, we also
detected reactive astrocytes in our cultures. Our findings are
consistent with studies demonstrating that incubation of astrocytic
cultures with neuronal-derived aSyn triggered aSyn aggregation in
these cells, along with changes in the levels of cytokines and
chemokines, a sign of an inflammatory response (55). In our study,
the inflammatory response we observe is intimately linked to
neuronal damage but independent of inclusion formation.
Furthermore, we investigated the intrinsic capacity of the spe-
cies tested to induce aSyn aggregation in the recipient cells. The
use of an antibody against S129 p-aSyn reveals a basal nuclear
aSyn phosphorylation in naïve neurons, compared with a more
punctate signal for total aSyn that is mostly present in the neu-
ronal processes. This finding is in agreement with the well-known
presynaptic location of aSyn and the enrichment of the phos-
phorylated form in the nuclear compartment (4, 56). According to
previous reports, we found that neurons exposed to aSyn aggre-
gates develop S129 p-aSyn inclusions, displaying increased levels
of insoluble aSyn (38, 49). However, in contrast to other studies
(39), overexpression of the cellular aSyn or expression of the hu-
man form was not required. The inclusions formed could be
classified depending on their localization in the cell. Neuritic and
perykarial inclusions have also been observed by others (49, 51, 57)
and colocalize with Hsp90, resembling pathology-related aggregates
(40). These inclusions are formed by both endogenous aSyn and
internalized recombinant species. On the other hand, we found
nuclear inclusions, which are excluded from the nucleoli. Despite
sporadic reports of the occurrence of aSyn aggregates in the nuclei
(58, 59), the morphology we observe has not, to the best of our
knowledge, been previously described. Nuclear inclusions are
ubiquitinated and exclusively formed by endogenous aSyn, as
recombinant species were not present in the nuclear compartment.
Integrating our findings with data from previous reports (38), aSyn
inclusion formation—upon stimulation from the outside—could
follow a progression pattern in which exogenous species are in-
ternalized, leading to the appearance of inclusions in the projec-
tions, and then in the cell body, upon partial sequestration of the
endogenous protein. Subsequently, nuclear inclusions appear, likely
through a different mechanism because they do not contain de-
tectable amounts of the exogenous protein. Given the apparent
lack of seeding capacity of H50Q +Cu2+ aggregates in vitro, addi-
tional studies will be required to unravel the cellular mechanisms by
which endogenous S129 p-aSyn inclusions form in the nucleus, once
the cytoplasm has been invaded by exogenous material.
In general, inclusion formation upon aSyn transmission is a
phenomenon highly dependent on the type of exogenous species
the cell encounters. We found that WT –Cu2+ aggregates rarely
induce inclusion formation in the cells, in contrast with previous
studies (49, 51), possibly because of different experimental ap-
proaches. In contrast, cells treated with aggregates formed in the
presence of Cu2+, particularly H50Q +Cu2+, promote the for-
mation of the various types of inclusions we identified. However,
we cannot explain why previous studies failed to observe nuclear
aSyn inclusions. A possible explanation could be the actual na-
ture of the H50Q +Cu2+ aggregates, which display different
biophysical features. Recent studies suggest that aSyn can adopt
various conformations with distinctive characteristics, including
distinct propagation capacity (53). These discoveries led to the
assumption that aSyn could assemble as different strains in vitro,
a hypothesis that has been recently tested in rats (58). In the
present study, we demonstrate that structurally different aSyn
species exert distinct effects when applied to neuronal cells, and
that these effects might be because of the presence of Cu2+
during the aggregation process, a situation that may occur in the
brain, a result of different environmental stimuli.
A final observation from our experiments is the dissociation
between toxicity and inclusion formation, in agreement with
other studies (52, 60, 61). WT +Cu2+ and H50Q +Cu2+ are the
less-damaging aggregates and the ones that promote to a larger
extent inclusion formation. Although so far we cannot identify
the causes of this fact, similar observations were previously
reported (62–66). Inclusion bodies were demonstrated to be
protective in the case of the Huntington’s disease-related protein
huntingtin (67). This was also observed in the case of nuclear
huntingtin inclusions (68). Importantly, the nuclear aSyn inclu-
sions we describe herein resemble those found in Huntington’s
disease-affected brains, given that they are ubiquitinated and
have similar size and morphology (69).
It is also possible that aSyn species exert toxicity from the
outside, without the need to enter the recipient cell. In that case,
the most aggressive species would induce cell death, avoiding the
lag time necessary to be internalized and trigger inclusion for-
mation. Indeed, toxicity exerted by exogenous aSyn species has
been reported, particularly in the case of aSyn oligomers (13).
The disruption of membrane integrity and permeability is one of
the possible molecular mechanisms involved (70); this could
promote calcium influx and deregulation of cellular homeostasis
(52). Although unlikely, because we used mature aggregates at
the end point of the aggregation reaction, it is possible that the
presence of residual oligomers in our samples may contribute to














the toxic effects observed. Finally, it is also possible that the
intrinsic toxicity of the recombinant species hamper their own
self-propagation. Recently, it was demonstrated that an increase
in aSyn aggregation is not associated with stronger neuronal
injury, arguing that efficient propagation of the protein is an
active process, where healthy cellular metabolism and connec-
tions are necessary (61). In addition, injection of two different
aSyn strains in vivo demonstrated that although both strains in-
duce the formation of p-aSyn inclusions, this effect is reduced in
the case of the most toxic strain, confirming that under certain
conditions, there is an inverse correlation between seeding and
damaging capacity (58).
In total, our study characterized the effects of various forms of
aSyn aggregates in the intracellular milieu. Ultimately, the un-
ambiguous dissociation between inclusion formation and toxicity
will be essential to guide the development of future therapeutic
approaches against synucleinopathies.
Materials and Methods
Purification of aSyn. aSynWT and H50Q were produced as previously described
(71, 72), using ammonium sulfate precipitation and ion-exchange chroma-
tography. For further details, see SI Appendix, SI Materials and Methods.
Aggregation of aSyn. aSyn was aggregated at 70 μM in the presence or ab-
sence of CuCl2 at 70 μM. Aggregation kinetics were conducted at 37 °C
under agitation and followed by Th-T binding. Sedimentation assays were
carried out by measuring the remaining soluble protein at the end time
point of aggregation. Aggregation kinetics of aSyn in the presence of dif-
ferent Cu2+ concentrations and iron were performed in a 96-well plate with
Teflon-balls, as previously described (73). For live cell imaging, aSyn aggre-
gates were labeled with ATTO 590 NHS-ester (Atto-Tec) as previously de-
scribed (50). For further details, see SI Appendix, SI Materials and Methods.
Circular Dichroism. CD spectra were obtained at a spectral resolution of 1 cm–1
and 15 nm·min–1 scan rate and collected over the 190- to 260-nm wave-
length range at 25 °C using a Jasco 810 spectropolarimeter with a quartz cell
of 0.1-cm path length. For the soluble state measurements, solutions at
10 μM were filtered through a 0.22-μM filter. At the end time point of ag-
gregation, samples were diluted to 10 μM and vigorously homogenized in
PBS before the measurements.
FTIR. ATR–FTIR spectra of the aSyn aggregates were obtained with Bruker
Tensor 27 FTIR spectrometer (Bruker Optics). For further details, see SI Ap-
pendix, SI Materials and Methods.
ANS Binding Assays. The assays were performed by incubating 5 μM of ag-
gregated samples with 20 μM of ANS in PBS. ANS fluorescence was measured
on an ISS K2 spectrofluorometer. Samples were excited at 370 nm, and the
emissions were collected from 400 to 600 nm using slits of 0.5 cm. The in-
tensity at 374 nm was used to compare the extent of ANS bound to each
sample. Assays with the soluble proteins were carried out by incubating
70 μM of the monomeric samples with 70 μM of ANS (soluble Transthyretin
was used as positive control).
Transmission Electron Microscopy. Aggregated samples were adsorbed onto
carbon-coated grids, rinsed with water, and stained with 2% (wt/vol) uranyl
acetate. The samples were exhaustively scanned and representative fields were
imaged in a Hitachi H-7000 TEM operating at an accelerating voltage of 75 kV.
PK Digestion Analysis. PK digestions of aSyn aggregates at the indicated time
points were conducted at 37 °C. The resulting fragments were analyzed in
Tricine-based protein electrophoresis. For further details, see SI Appendix, SI
Materials and Methods.
NMR Spectroscopy. NMR experiments were recorded at 37 °C on a Bruker Avance
600 MHz spectrometer. To assess the seeding capabilities of different aggre-
gates, a 4% concentration (vol/vol) of preformed aggregates, as described above
WT –Cu2+, WT +Cu2+, H50Q –Cu2+, H50Q +Cu2+, were added to a 70-μM con-
centration of the fresh monomeric protein (in the absence or presence of an
equimolar concentration of Cu2+). The NMR buffer was 25 mM Hepes, 100 mM
NaCl at pH 7.4, 90% H2O/10% D2O (vol/vol).
1H NMR spectra were recorded
every 2 h for at least 20 h after the addition of seeds. The reduction in signal
intensity reports on the decrease in the concentration of monomeric protein.
Molecular Simulations. Details on the methodology are found in SI Appendix,
SI Molecular Simulations.
Human Cell Cultures. Human H4 cells were treated, 24 h after transfection, with
1 μM of CuCl2. For further details, see SI Appendix, SI Materials and Methods.
Primary Cell Cultures. Preparation of primary cortical cultures from WT rats
was carried out as previously described (74). Cells were treated with 1 μM of
aSyn aggregates. For live cell imaging, neurons were infected with a GFP-
overexpressing lentivirus previous to the application of aSyn prelabeled
aggregates. For further details, see SI Appendix, SI Materials and Methods.
Immunostaining Studies. Cells were fixed with paraformaldehyde and, when
appropriate,with additionof 1%TritonX-100 to remove soluble structures (38).
After permeabilization and blocking, cells were incubated with primary anti-
bodies overnight at 4 °C and subsequently with Alexa Fluor-conjugated sec-
ondary antibodies. Leica DMI 6000B and Olympus XI81 microscopes were used
for imaging. For further details, see SI Appendix, SI Materials and Methods.
Immunoblotting Analysis. Cells were lysed with a native buffer containing 1%
Triton X-100 and cell debris was discarded by centrifugation. Cell lysates were
separated in SDS/PAGE gels and transferred to blotting membranes, which
were subsequently blocked with 5% (wt/vol) milk. Primary and secondary
antibodies were incubated overnight at 4 °C and for 1 h at room tempera-
ture, respectively, and membranes were developed. For further details, see
SI Appendix, SI Materials and Methods.
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